Fig. 1From: Successful treatment with anti-programmed-death-1 antibody in a relapsed natural killer/T-cell lymphoma patient with multi-line resistance: a case reportDouble lower limbs ulcers after relapse. a Before pembrolizumab. b Response to pembrolizumab after one cycle of treatment. c Ongoing response to pembrolizumab after four cycles of treatmentBack to article page